605 related articles for article (PubMed ID: 26472914)
21. STRUCTURAL BIOLOGY. Chromatin complex, crystal clear.
Schapira M
Science; 2015 Oct; 350(6258):278-9. PubMed ID: 26472895
[No Abstract] [Full Text] [Related]
22. Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2).
Xu C; Bian C; Yang W; Galka M; Ouyang H; Chen C; Qiu W; Liu H; Jones AE; MacKenzie F; Pan P; Li SS; Wang H; Min J
Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19266-71. PubMed ID: 20974918
[TBL] [Abstract][Full Text] [Related]
23. Non-core Subunits of the PRC2 Complex Are Collectively Required for Its Target-Site Specificity.
Højfeldt JW; Hedehus L; Laugesen A; Tatar T; Wiehle L; Helin K
Mol Cell; 2019 Nov; 76(3):423-436.e3. PubMed ID: 31521506
[TBL] [Abstract][Full Text] [Related]
24. Epigenomic Regulation of Schwann Cell Reprogramming in Peripheral Nerve Injury.
Ma KH; Hung HA; Svaren J
J Neurosci; 2016 Aug; 36(35):9135-47. PubMed ID: 27581455
[TBL] [Abstract][Full Text] [Related]
25. Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance.
Brooun A; Gajiwala KS; Deng YL; Liu W; Bolaños B; Bingham P; He YA; Diehl W; Grable N; Kung PP; Sutton S; Maegley KA; Yu X; Stewart AE
Nat Commun; 2016 Apr; 7():11384. PubMed ID: 27122193
[TBL] [Abstract][Full Text] [Related]
26. An Evolutionarily Conserved Structural Platform for PRC2 Inhibition by a Class of Ezh2 Inhibitors.
Bratkowski M; Yang X; Liu X
Sci Rep; 2018 Jun; 8(1):9092. PubMed ID: 29904056
[TBL] [Abstract][Full Text] [Related]
27. Polycomb-dependent H3K27me1 and H3K27me2 regulate active transcription and enhancer fidelity.
Ferrari KJ; Scelfo A; Jammula S; Cuomo A; Barozzi I; Stützer A; Fischle W; Bonaldi T; Pasini D
Mol Cell; 2014 Jan; 53(1):49-62. PubMed ID: 24289921
[TBL] [Abstract][Full Text] [Related]
28. A Dimeric Structural Scaffold for PRC2-PCL Targeting to CpG Island Chromatin.
Chen S; Jiao L; Liu X; Yang X; Liu X
Mol Cell; 2020 Mar; 77(6):1265-1278.e7. PubMed ID: 31959557
[TBL] [Abstract][Full Text] [Related]
29. Identification and Assessments of Novel and Potent Small-Molecule Inhibitors of EED-EZH2 Interaction of Polycomb Repressive Complex 2 by Computational Methods and Biological Evaluations.
Zhu K; Du D; Yang R; Tao H; Zhang H
Chem Pharm Bull (Tokyo); 2020 Jan; 68(1):58-63. PubMed ID: 31685780
[TBL] [Abstract][Full Text] [Related]
30. Discovery of Peptidomimetic Ligands of EED as Allosteric Inhibitors of PRC2.
Barnash KD; The J; Norris-Drouin JL; Cholensky SH; Worley BM; Li F; Stuckey JI; Brown PJ; Vedadi M; Arrowsmith CH; Frye SV; James LI
ACS Comb Sci; 2017 Mar; 19(3):161-172. PubMed ID: 28165227
[TBL] [Abstract][Full Text] [Related]
31. Regulation of Retinal Development via the Epigenetic Modification of Histone H3.
Watanabe S; Murakami A
Adv Exp Med Biol; 2016; 854():635-41. PubMed ID: 26427469
[TBL] [Abstract][Full Text] [Related]
32. Propagation of trimethylated H3K27 regulated by polycomb protein EED is required for embryogenesis, hematopoietic maintenance, and tumor suppression.
Ueda T; Nakata Y; Nagamachi A; Yamasaki N; Kanai A; Sera Y; Sasaki M; Matsui H; Honda Z; Oda H; Wolff L; Inaba T; Honda H
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10370-5. PubMed ID: 27578866
[TBL] [Abstract][Full Text] [Related]
33. Discovery of selective activators of PRC2 mutant EED-I363M.
Suh JL; Barnash KD; Abramyan TM; Li F; The J; Engelberg IA; Vedadi M; Brown PJ; Kireev DB; Arrowsmith CH; James LI; Frye SV
Sci Rep; 2019 Apr; 9(1):6524. PubMed ID: 31024026
[TBL] [Abstract][Full Text] [Related]
34. Allosteric Inactivation of Polycomb Repressive Complex 2 (PRC2) by Inhibiting Its Adapter Protein: Embryonic Ectodomain Development (EED).
Yang CY; Wang S
J Med Chem; 2017 Mar; 60(6):2212-2214. PubMed ID: 28256832
[TBL] [Abstract][Full Text] [Related]
35. Identification of catalytic and non-catalytic activity inhibitors against PRC2-EZH2 complex through multiple high-throughput screening campaigns.
Zhou Y; Du DH; Wang J; Cai XQ; Deng AX; Nosjean O; Boutin JA; Renard P; Yang DH; Luo C; Wang MW
Chem Biol Drug Des; 2020 Oct; 96(4):1024-1051. PubMed ID: 32394628
[TBL] [Abstract][Full Text] [Related]
36. Tudor domains of the PRC2 components PHF1 and PHF19 selectively bind to histone H3K36me3.
Qin S; Guo Y; Xu C; Bian C; Fu M; Gong S; Min J
Biochem Biophys Res Commun; 2013 Jan; 430(2):547-53. PubMed ID: 23228662
[TBL] [Abstract][Full Text] [Related]
37. Recent Structural Insights into Polycomb Repressive Complex 2 Regulation and Substrate Binding.
Kasinath V; Poepsel S; Nogales E
Biochemistry; 2019 Feb; 58(5):346-354. PubMed ID: 30451485
[TBL] [Abstract][Full Text] [Related]
38. Dense chromatin activates Polycomb repressive complex 2 to regulate H3 lysine 27 methylation.
Yuan W; Wu T; Fu H; Dai C; Wu H; Liu N; Li X; Xu M; Zhang Z; Niu T; Han Z; Chai J; Zhou XJ; Gao S; Zhu B
Science; 2012 Aug; 337(6097):971-5. PubMed ID: 22923582
[TBL] [Abstract][Full Text] [Related]
39. C10ORF12 modulates PRC2 histone methyltransferase activity and H3K27me3 levels.
Shi Y; Ma HL; Zhuang YW; Wang XX; Jiang Y; Xu HE
Acta Pharmacol Sin; 2019 Nov; 40(11):1457-1465. PubMed ID: 31186533
[TBL] [Abstract][Full Text] [Related]
40. Polycomb recruitment at the Class II transactivator gene.
Boyd NH; Morgan JE; Greer SF
Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
